Guo‐He Lin

548 total citations
37 papers, 427 citations indexed

About

Guo‐He Lin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Guo‐He Lin has authored 37 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 12 papers in Surgery. Recurrent topics in Guo‐He Lin's work include Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Lung Cancer Research Studies (6 papers). Guo‐He Lin is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Lung Cancer Research Studies (6 papers). Guo‐He Lin collaborates with scholars based in China, United States and Switzerland. Guo‐He Lin's co-authors include Shengping Li, Bi‐Cheng Wang, Shuhong Li, Xiang‐Ming Lao, Yize Mao, Jianlin Chen, Zeyu Shuang, Jun Wang, Limin Zheng and Jing Xu and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

In The Last Decade

Guo‐He Lin

35 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guo‐He Lin China 10 266 118 107 103 82 37 427
Muhammad Zubair Afzal United States 11 383 1.4× 166 1.4× 65 0.6× 143 1.4× 98 1.2× 31 543
Guangyu An China 13 260 1.0× 106 0.9× 72 0.7× 115 1.1× 54 0.7× 24 416
Steffen Heeg Germany 11 240 0.9× 273 2.3× 110 1.0× 38 0.4× 87 1.1× 26 509
Ekaterini Politi Greece 10 220 0.8× 170 1.4× 53 0.5× 127 1.2× 80 1.0× 15 427
Ryotaro Ogawa Japan 8 344 1.3× 202 1.7× 47 0.4× 232 2.3× 132 1.6× 16 587
Takuro Yukawa Japan 13 366 1.4× 115 1.0× 44 0.4× 232 2.3× 98 1.2× 37 614
Émilie Varey France 13 214 0.8× 135 1.1× 85 0.8× 197 1.9× 101 1.2× 28 491
Xianchao Lin China 13 294 1.1× 168 1.4× 96 0.9× 169 1.6× 93 1.1× 36 502
Nathan Tonlaar United States 6 179 0.7× 117 1.0× 84 0.8× 154 1.5× 150 1.8× 13 414

Countries citing papers authored by Guo‐He Lin

Since Specialization
Citations

This map shows the geographic impact of Guo‐He Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo‐He Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo‐He Lin more than expected).

Fields of papers citing papers by Guo‐He Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guo‐He Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo‐He Lin. The network helps show where Guo‐He Lin may publish in the future.

Co-authorship network of co-authors of Guo‐He Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Guo‐He Lin. A scholar is included among the top collaborators of Guo‐He Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guo‐He Lin. Guo‐He Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Bi‐Cheng, et al.. (2024). Durvalumab and pembrolizumab in advanced biliary tract cancer: a reconstructed patient-level mimic head-to-head comparative analysis. Frontiers in Immunology. 15. 1497415–1497415. 1 indexed citations
2.
Zhang, Wenxuan, et al.. (2024). Tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: an effective analysis based on real-world retrospective studies. Frontiers in Endocrinology. 15. 1345203–1345203. 4 indexed citations
3.
Wang, Bi‐Cheng, et al.. (2024). Emerging chemotherapy-based treatments in anaplastic thyroid cancer: an updated analysis of prospective studies. Frontiers in Endocrinology. 15. 1385747–1385747. 3 indexed citations
4.
5.
6.
Wang, Bi‐Cheng, Chen Fu, & Guo‐He Lin. (2023). The efficacy of adebrelimab compared with durvalumab and atezolizumab in untreated extensive-stage small-cell lung cancer: a survival analysis of reconstructed patient-level data. Frontiers in Immunology. 14. 1185577–1185577. 6 indexed citations
7.
Wang, Bi‐Cheng, et al.. (2022). Induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A systematic review and meta-analysis. Frontiers in Oncology. 12. 927510–927510. 5 indexed citations
8.
9.
Wang, Bi‐Cheng, et al.. (2021). Doxorubicin/Adriamycin Monotherapy or Plus Ifosfamide in First-Line Treatment for Advanced Soft Tissue Sarcoma: A Pooled Analysis of Randomized Trials. Frontiers in Oncology. 11. 762288–762288. 8 indexed citations
10.
11.
Wang, Bi‐Cheng, et al.. (2021). 6 versus 12 months of adjuvant trastuzumab in HER2+ early breast cancer. Medicine. 100(10). e24995–e24995. 1 indexed citations
12.
13.
Lin, Guo‐He, et al.. (2020). <p>Efficacy and Safety of Apatinib Treatment for Patients with Advanced Intrahepatic Cholangiocarcinoma</p>. Cancer Management and Research. Volume 12. 11523–11526. 1 indexed citations
14.
Lin, Guo‐He, et al.. (2020). The efficacy and safety of PD-1/PD-L1 inhibitors in breast cancer: a systematic review and meta-analysis. Translational Cancer Research. 9(6). 3804–3818. 9 indexed citations
15.
Huang, Xin, Chaobin He, Guo‐He Lin, et al.. (2020). Induced CD10 expression during monocyte-to-macrophage differentiation identifies a unique subset of macrophages in pancreatic ductal adenocarcinoma. Biochemical and Biophysical Research Communications. 524(4). 1064–1071. 19 indexed citations
16.
17.
Wang, Bi‐Cheng, et al.. (2020). Efficacy and safety of gemcitabine plus capecitabine in the treatment of advanced or metastatic pancreatic cancer: a systematic review and meta-analysis. Annals of Palliative Medicine. 9(4). 1631–1642. 6 indexed citations
18.
19.
20.
Lin, Guo‐He, Jin Wang, Xiang‐Ming Lao, et al.. (2012). Interleukin-6 Inhibits Regulatory T Cells and Improves the Proliferation and Cytotoxic Activity of Cytokine-induced Killer Cells. Journal of Immunotherapy. 35(4). 337–343. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Muhammad Zubair Afzal Breakdown of academic impact, for papers by Guangyu An Breakdown of academic impact, for papers by Steffen Heeg Breakdown of academic impact, for papers by Ekaterini Politi Breakdown of academic impact, for papers by Ryotaro Ogawa Breakdown of academic impact, for papers by Takuro Yukawa Breakdown of academic impact, for papers by Émilie Varey Breakdown of academic impact, for papers by Xianchao Lin Breakdown of academic impact, for papers by Nathan Tonlaar
Rankless by CCL
2026